NCT00508625 A Study of AMG 951 [rhApo2L/TRAIL] in Subjects With Previously Untreated Non-Small Cell Lung Cancer (NSCLC) Treated With Chemotherapy +/- Bevacizumab Status COMPLETED Phase PHASE2
NCT00507429 Study of Combretastatin and Paclitaxel/Carboplatin in the Treatment of Anaplastic Thyroid Cancer Status TERMINATED Phase PHASE2/PHASE3
NCT00505492 Malignant Mixed Mesodermal Tumor (MMMT) - Early Stage With Postoperative XRT/Chemotherapy Status TERMINATED Phase PHASE2
NCT00502892 Topotecan, Ifosfamide and Carboplatin in Children and Young Adults With Solid Tumors Status COMPLETED Phase PHASE1
NCT00502203 Paclitaxel and Carboplatin in Women With Malignant Mixed Mullerian Tumors (MMMT) of the Uterus Status COMPLETED Phase PHASE2
NCT00501644 Chemoimmunotherapy Study for Patients With Epithelial Ovarian Cancer Status COMPLETED Phase PHASE2
NCT00499616 Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma Status COMPLETED Phase PHASE3
NCT00499109 Phase III of RRM1 & ERCC1 Directed Customized Chemotherapy for the Treatment of Patients With NSCLC Status COMPLETED Phase PHASE3
NCT00498953 Combination Chemotherapy and Radiation Therapy With or Without Lapatinib in Treating Patients With Locally Advanced Cancer of the Larynx or Hypopharynx Status COMPLETED Phase PHASE1/PHASE2
NCT00495170 Concurrent Proton and Chemotherapy in Locally Advanced Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE2
NCT00494182 Sorafenib in Combination With Carboplatin and Paclitaxel in Treating Participants With Metastatic or Recurrent Head and Neck Squamous Cell Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT00494026 Chemotherapy and Radiotherapy to Treat Patients With Limited Stage of Small Cell Lung Cancer (SCLC) Status TERMINATED Phase PHASE2
NCT00492687 Radiation Therapy, Temozolomide, Tamoxifen, and Carboplatin in Treating Patients With Malignant Gliomas Status UNKNOWN Phase PHASE2
NCT00490711 Treatment of Paclitaxel Plus Carboplatin Followed by Gemcitabine Plus Carboplatin for Patients With Epithelial Ovarian Cancer Status COMPLETED Phase PHASE2
NCT00486356 Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer Status COMPLETED Phase PHASE1
NCT00483782 Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Newly Diagnosed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer Status COMPLETED Phase PHASE3
NCT00483223 Platinum for Triple-Negative Metastatic Breast Cancer and Evaluation of p63/p73 as a Biomarker of Response Status COMPLETED Phase PHASE2
NCT00482014 A Study of Pemetrexed Plus Carboplatin, or Pemetrexed Plus Cisplatin With Radiation Therapy Followed by Pemetrexed in Patients With Inoperable Non-Small-Cell Lung Cancer Status COMPLETED Phase PHASE1/PHASE2